Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

by Element Science

ClearRead CT

by RIVERAIN TECHNOLOGIES

AI Verdict

Tool A, the Jewel Patch WCD, is a wearable device for continuous monitoring and treatment of life-threatening arrhythmias, focusing on active cardiac rhythm management. In contrast, Tool B, ClearRead CT, is an AI suite for diagnostic imaging, enhancing the detection of pulmonary nodules and analyzing coronary artery calcification from CT scans. While both utilize AI in cardiology, their distinct applications lie in real-time therapeutic intervention versus diagnostic imaging analysis.

Choose Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) if…

Choose Jewel Patch Wearable Cardioverter Defibrillator if your patient requires continuous, discreet cardiac monitoring and immediate, life-saving defibrillation therapy outside of a hospital setting. This water-resistant, patch-based device is ideal for individuals at high risk of sudden cardiac arrest who need a highly compliant solution for ongoing arrhythmia detection and treatment.

View Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) →

Choose ClearRead CT if…

Choose ClearRead CT if your radiology department seeks to enhance the accuracy and efficiency of cardiothoracic CT scan interpretations. This AI suite is best suited for improving pulmonary nodule detection, characterization, and tracking, as well as for precise coronary artery calcification scoring, ultimately streamlining radiologist workflows.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)	ClearRead CT
Pricing	Unknown	Contact for pricing
Deployment	Wearable device with mobile app	On-premise (stand-alone server, virtual machine) and Cloud
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Tool A, the Jewel Patch, prioritizes patient usability with its discreet, water-resistant, patch-based design, leading to high patient compliance (over 23 hours/day wear time). Its associated mobile app also offers near real-time therapy information to the medical team, streamlining patient management.

Clinical Value

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

While both tools offer significant clinical value, Tool A, the Jewel Patch, directly provides continuous heart monitoring and treatment of life-threatening arrhythmias, including delivering defibrillation shocks. This direct therapeutic intervention for critical conditions gives it a slight edge in immediate, life-saving clinical impact.

Pricing & Value

Tie

Both Tool A and Tool B state that pricing information is not publicly available and requires contacting the vendor. Without transparent pricing details for either product, it is impossible to conduct a head-to-head comparison on this dimension.

Enterprise Readiness

ClearRead CT

Tool B, ClearRead CT, explicitly offers flexible deployment options including on-premise (stand-alone server, virtual machine) and cloud, catering to diverse enterprise IT infrastructures. Its mention of operating with the VA and other healthcare institutions also suggests robust experience with large-scale deployments.

Innovation

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Tool A, the Jewel Patch, demonstrates significant innovation with its patch-based, water-resistant wearable cardioverter defibrillator, offering continuous, active treatment in a highly patient-centric and discreet form factor. This represents a notable advancement in WCD technology for patient comfort and adherence.

Support & Docs

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Tool A provides publicly accessible product manuals, patient guides, physician instructions, and instructional videos for its device and app. Furthermore, it offers 24/7 customer service via phone and email, ensuring constant support for users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)	ClearRead CT
Product Name	Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)	ClearRead CT
Description	A water-resistant, patch-based device with a machine learning algorithm for continuous heart monitoring and treatment of life-threatening arrhythmias, designed for high patient compliance.	An FDA-cleared AI suite for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology.
Company	Element Science, Inc.	RIVERAIN TECHNOLOGIES
Key AI Application	Machine learning detection algorithm for arrhythmia detection; continuous heart rhythm monitoring.	Enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans; patented vessel suppression.
Target Specialties	Cardiology	Cardiology, Pulmonology, Radiology
Specific Features	Water-resistant design for continuous wear; detects and treats specific life-threatening arrhythmias; high patient compliance (median wear time over 23 hours/day).	Pulmonary Nodule Detection (solid, part-solid, ground glass); Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs); automated nodule tracking and comparison to prior exams.

Videos

Demos, reviews, and walkthroughs featuring Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) and ClearRead CT.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and what is the depth of their EHR integration?

The Jewel P-WCD utilizes an associated Jewel Mobile App to provide near real-time therapy information to the medical team, facilitating digital data flow for clinical review. ClearRead CT offers seamless PACS integration and vendor-neutral processing, allowing it to fit directly into existing radiology reading workflows and streamline the incorporation of AI-enhanced findings into diagnostic reports.

What specific improvements in diagnostic accuracy or clinical outcomes can physicians expect from each tool?

The Jewel P-WCD is designed for continuous heart monitoring and treatment of life-threatening arrhythmias using a machine learning algorithm, with high patient compliance (median wear time over 23 hours/day) supporting continuous data collection for timely intervention. ClearRead CT improves detection accuracy with a reported 29% reduction in missed actionable nodules and can reduce reading times by up to 36%. It also enhances pulmonary nodule detection and coronary artery calcification analysis in CT scans.

In what specific clinical contexts or patient populations would each tool provide the most significant benefit to a physician?

The Jewel P-WCD is most beneficial for cardiology patients requiring continuous heart monitoring and potential defibrillation for life-threatening arrhythmias, especially those who would benefit from a discreet, water-resistant, and highly compliant wearable device. ClearRead CT offers significant diagnostic advantages for radiologists, pulmonologists, and cardiologists interpreting CT scans, particularly for enhancing the detection and characterization of pulmonary nodules and for coronary artery calcification scoring.

What is the expected learning curve for physicians and their teams, and how quickly can a practice realize value from implementing each tool?

The Jewel P-WCD is a patch-based device with an associated mobile app, implying a learning curve for device application, patient education, and data interpretation from the app. High patient compliance (over 23 hours/day) suggests a quicker path to consistent data collection and clinical insights. ClearRead CT is designed to streamline radiology workflows and reduce reading times by up to 36%, indicating a potential for rapid operational value once integrated into PACS. Its AI-driven clarity aims for faster and more confident nodule detection, contributing to quicker diagnostic throughput.

Beyond standard compliance, what specific security measures or audit-trail features are in place to protect patient data and ensure accountability for each tool?

The Jewel P-WCD involves a hardware device with an associated mobile application and cloud-based digital health platform, necessitating robust security for continuous cardiac data transmission and storage of sensitive patient health information. ClearRead CT integrates with PACS and offers automated nodule tracking and comparison to prior exams, which can serve as an internal audit trail for diagnostic consistency and changes over time. Its operation within healthcare institutions like the VA suggests adherence to stringent security protocols for imaging data.